Scotiabank analyst Greg Harrison lowered the firm’s price target on Vera Therapeutics (VERA) to $55 from $60 and keeps an Outperform rating on the ...

Scotiabank analyst Greg Harrison lowered the firm’s price target on Apellis (APLS) to $20 from $28 and keeps a Sector Perform rating on the shares.The company had a weak Q1, with Syfovre ...

Members of Congress have traded $VRTX stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales. Here’s a breakdown of recent ...

An Akron Public Schools board member said he plans to make a motion at Monday's board meeting to have the superintendent put on administrative leave. The Rev. Greg Harrison said Tuesday that ...

Scotiabank analyst Greg Harrison lowered the firm’s price target on Travere Therapeutics (TVTX) to $30 from $32 and keeps an Outperform rating on the shares. The company recently presented ...